Alkem Laboratories Ltd (ALKEM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1000019,
    "name": "Alkem Lab",
    "stock_name": "Alkem Lab",
    "full_name": "Alkem Laboratories Ltd",
    "name_url": "stocks-analysis/alkem-lab",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "5,159.50",
    "chg": -77,
    "chgp": "-1.47%",
    "dir": -1,
    "prev_price": "5,236.50",
    "mcapval": "61,689.56 Cr",
    "mcap": "Mid Cap",
    "scripcode": 539523,
    "symbol": "ALKEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE540L01014",
    "curr_date": "Apr 07",
    "curr_time": "",
    "bse_nse_vol": "1.05 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 07, 2026",
    "traded_date_str": "2026 04 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alkem-lab-1000019-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Alkem Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-ltd-is-rated-sell-3934877",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlkemLaboratori_mojoScore_3934877.png",
        "date": "2026-04-07 10:10:45",
        "description": "Alkem Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3920105",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_oi_spurts_by_underlying_3920105.png",
        "date": "2026-03-27 15:00:58",
        "description": "Alkem Laboratories Ltd has witnessed a significant 43.6% surge in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This sudden spike in open interest, coupled with volume patterns and shifting market positioning, suggests evolving investor sentiment and potential directional bets in the mid-cap pharmaceutical player."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3919872",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_oi_spurts_by_underlying_3919872.png",
        "date": "2026-03-27 14:00:42",
        "description": "Alkem Laboratories Ltd has witnessed a significant 38.2% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock underperformed its sector and broader indices, reflecting a complex interplay of bullish and bearish sentiments among traders."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3919541",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_oi_spurts_by_underlying_3919541.png",
        "date": "2026-03-27 13:00:26",
        "description": "Alkem Laboratories Ltd has witnessed a significant 29.4% surge in open interest in its derivatives segment, signalling heightened market activity despite the stock underperforming its sector and broader indices. This sudden spike in open interest, coupled with volume patterns and price movements, suggests evolving market positioning and potential directional bets among traders."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3919117",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_oi_spurts_by_underlying_3919117.png",
        "date": "2026-03-27 12:00:12",
        "description": "Alkem Laboratories Ltd has witnessed a notable 18.14% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with volume patterns and shifting investor positioning, offers critical insights into potential directional bets and market sentiment for this mid-cap pharmaceutical player."
      },
      {
        "title": "Alkem Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-ltd-is-rated-sell-3918865",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_mojoScore_3918865.png",
        "date": "2026-03-27 10:10:41",
        "description": "Alkem Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 27 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3916531",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_oi_spurts_by_underlying_3916531.png",
        "date": "2026-03-25 15:01:03",
        "description": "Alkem Laboratories Ltd has witnessed a significant 18.6% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a moderate 2.5% gain in the stock price, the underlying volume and open interest dynamics suggest nuanced directional bets amid a cautiously optimistic pharmaceutical sector backdrop."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3916392",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_oi_spurts_by_underlying_3916392.png",
        "date": "2026-03-25 14:00:48",
        "description": "Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The pharmaceutical mid-cap stock outperformed its sector peers with a 2.87% gain on 25 Mar 2026, supported by a 15.48% rise in open interest and robust volume patterns, reflecting evolving investor positioning ahead of upcoming catalysts."
      },
      {
        "title": "Alkem Laboratories Sees Significant Open Interest Surge Amid Bullish Derivatives Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-significant-open-interest-surge-amid-bullish-derivatives-activity-3916293",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_oi_spurts_by_underlying_3916293.png",
        "date": "2026-03-25 13:00:37",
        "description": "Alkem Laboratories Ltd has witnessed a notable 12.78% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent upgrade to a Sell rating by MarketsMOJO, the stock has outperformed its sector and broader indices over the past two days, reflecting a complex interplay of bullish and bearish sentiments among traders."
      }
    ],
    "total": 529,
    "sid": "1000019",
    "stock_news_url": "https://www.marketsmojo.com/news/alkem-laboratories-1000019"
  },
  "announcements": [
    {
      "details": "Alkem Laboratories Limited has informed the Exchange regarding 'Intimation of Opening of Trading Window'.",
      "source": "NSE",
      "caption": "Alkem Laboratories Limited - Updates",
      "datetime": "13-Nov-2019"
    },
    {
      "details": "Alkem Laboratories Limited has informed the Exchange regarding a press release dated November 01, 2019, titled \"Closure of US FDA Inspection at Alkem s manufacturing facility located at Daman, India and Baddi, India. \".",
      "source": "NSE",
      "caption": "Alkem Laboratories Limited - Press Release",
      "datetime": "01-Nov-2019"
    },
    {
      "details": "Alkem Laboratories Limited has informed the Exchange regarding a press release dated October 22, 2019, titled \"Update on US FDA Inspection at Alkem s Bioequivalence Center at Taloja\".",
      "source": "NSE",
      "caption": "Alkem Laboratories Limited - Press Release",
      "datetime": "22-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alkem Laboratories Ltd has declared <strong>2150%</strong> dividend, ex-date: 20 Feb 26",
          "dt": "2026-02-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Alkem Laboratories Ltd is Rated Sell

2026-04-07 10:10:45

Alkem Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-03-27 15:00:58

Alkem Laboratories Ltd has witnessed a significant 43.6% surge in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This sudden spike in open interest, coupled with volume patterns and shifting market positioning, suggests evolving investor sentiment and potential directional bets in the mid-cap pharmaceutical player.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-03-27 14:00:42

Alkem Laboratories Ltd has witnessed a significant 38.2% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock underperformed its sector and broader indices, reflecting a complex interplay of bullish and bearish sentiments among traders.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-03-27 13:00:26

Alkem Laboratories Ltd has witnessed a significant 29.4% surge in open interest in its derivatives segment, signalling heightened market activity despite the stock underperforming its sector and broader indices. This sudden spike in open interest, coupled with volume patterns and price movements, suggests evolving market positioning and potential directional bets among traders.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-03-27 12:00:12

Alkem Laboratories Ltd has witnessed a notable 18.14% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with volume patterns and shifting investor positioning, offers critical insights into potential directional bets and market sentiment for this mid-cap pharmaceutical player.

Read full news article

Alkem Laboratories Ltd is Rated Sell

2026-03-27 10:10:41

Alkem Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 27 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-03-25 15:01:03

Alkem Laboratories Ltd has witnessed a significant 18.6% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a moderate 2.5% gain in the stock price, the underlying volume and open interest dynamics suggest nuanced directional bets amid a cautiously optimistic pharmaceutical sector backdrop.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-03-25 14:00:48

Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The pharmaceutical mid-cap stock outperformed its sector peers with a 2.87% gain on 25 Mar 2026, supported by a 15.48% rise in open interest and robust volume patterns, reflecting evolving investor positioning ahead of upcoming catalysts.

Read full news article

Alkem Laboratories Sees Significant Open Interest Surge Amid Bullish Derivatives Activity

2026-03-25 13:00:37

Alkem Laboratories Ltd has witnessed a notable 12.78% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent upgrade to a Sell rating by MarketsMOJO, the stock has outperformed its sector and broader indices over the past two days, reflecting a complex interplay of bullish and bearish sentiments among traders.

Read full news article

View All News